JPMorgan lowered the firm’s price target on DocuSign to $45 from $50 and keeps an Underweight rating on the shares. The company reported fiscal Q3 results that cleared a very conservative bar on revenue and billings, though with a softer magnitude of billings beat and ongoing deceleration in some key metrics, the analyst tells investors in a research note. The firm says macro headwinds remain for DocuSign.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DOCU:
- DocuSign (NASDAQ:DOCU) Posts Strong Q3 Performance
- DocuSign Announces Third Quarter Fiscal 2024 Financial Results
- Options Volatility and Implied Earnings Moves Today, December 07, 2023
- DOCU Upcoming Earnings Report: What to Expect?
- Options Volatility and Implied Earnings Moves This Week, December 04 – December 08, 2023